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Abstract
The current paradigm for causal inference in epidemiology relies primarily on the evalua-
tion of counterfactual contrasts via statistical regression models informed by graphical
causal models (often in the form of directed acyclic graphs, or DAGs) and their underly-
ing mathematical theory. However, there have been growing calls for supplementary
methods, and one such method that has been proposed is agent-based modelling due to
its potential for simulating counterfactuals. However, within the epidemiological litera-
ture, there currently exists a general lack of clarity regarding what exactly agent-based
modelling is (and is not) and, importantly, how it differs from microsimulation model-
ling—perhaps its closest methodological comparator. We clarify this distinction by
briefly reviewing the history of each method, which provides a context for their similari-
ties and differences, and casts light on the types of research questions that they have
evolved (and thus are well suited) to answering; we do the same for DAG-informed re-
gression methods. The distinct historical evolutions of DAG-informed regression model-
ling, microsimulation modelling and agent-based modelling have given rise to distinct
features of the methods themselves, and provide a foundation for critical comparison.
Not only are the three methods well suited to addressing different types of causal ques-
tions, but, in doing so, they place differing levels of emphasis on fixed and random
effects, and also tend to operate on different timescales and in different timeframes.
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Introduction
Epidemiology, which entails the study of both the distri-
bution and determinants of health and disease, is often
considered the core science of public health.1 Whilst easy
to conceptualize, it nevertheless remains difficult to prac-
tise. Population-level health patterns emerge from a com-
plex, dynamic, multi-layered system, in which a
multitude of different interrelationships operate2; this sys-
tem is commonly referred to in the literature as a ‘com-
plex system’, which is characterized by individual
heterogeneity and autonomy, interdependence, spillover
effects, adaptivity and evolution, feedback and threshold
effects.3 Individuals move through space and time, inter-
acting with and being influenced by other individuals,
groups, social, economic and political constraints, and ge-
ography—to name but a few. Understanding the impact
of individual behaviour and decision-making on popula-
tion health trends—so that we are ultimately able to inter-
vene to alter them beneficially—necessarily requires a
causal understanding of those patterns and processes that
are important, and at which spatial and temporal scales
they operate.
The inherent complexity of such a system poses chal-
lenges to anyone attempting to model it; identifying and
estimating causal effects creates additional challenges.
Causation is a concept of which most, if not all, human
beings have an intuitive understanding. Nevertheless, it is a
complex phenomenon and remains largely inarticulable;
despite thousands of years of philosophical discourse, there
exists very little consensus as to what it is, how it can be
defined4 and—perhaps most importantly for researchers—
how it can be inferred within practical research applica-
tions.5–10 To address this, many methods have emerged
across a range of different disciplines, though the current
paradigm for causal inference in epidemiology relies
primarily on the evaluation of counterfactual contrasts via
statistical regression models informed by graphical causal
models (often in the form of directed acyclic graphs, or
DAGs) and their underlying mathematical theory.5
However, there have been growing calls for a more plural-
istic approach to causal inference in the field,5,6,11 pre-
mised on the argument that there are numerous causal
scenarios that do not lend themselves to representation by
DAGs and subsequent statistical analyses.
Many authors have proposed more widespread adoption
of ‘systems approaches’2,3,12–15—a somewhat nebulous
term for a group of methods that may be used to study the
nature of systems. In particular, several authors have identi-
fied agent-based models (ABMs) as promising tools for
causal inference in complex systems, as they provide a
framework for the simulation of counterfactuals.15–17
Perhaps due to agent-based modelling having primarily
evolved within and been adopted by the ‘softer’ social scien-
ces (e.g. sociology, political science), it remains relatively
unfamiliar to epidemiological researchers; moreover, there
appears to be little clarity regarding what exactly an ABM is
(and is not) and, importantly, how it differs from other sim-
ulation models. For example, the recent work of Murray
et al.18 demonstrated equivalence between the parametric g-
formula (a statistical method based upon graphical model
theory) and what the authors referred to as agent-based
modelling, though, in actuality, it is more akin to microsi-
mulation modelling. Whilst the distinction between ABMs
and microsimulation models (MSMs) may seem self-evident
to those who regularly use these methods and trivial to those
who do not, it does in fact have important implications for
how and under which circumstances each may be used, and
thus is worth clarifying.
To this end, we seek to elucidate the distinction be-
tween microsimulation modelling and agent-based
Key Messages
• Microsimulation modelling and agent-based modelling are closely linked methodologically though historically dis-
tinct. The key features of agent-based modelling are agency and agent-to-agent interaction, which produce highly
complex and ‘emergent’ properties.
• Directed acyclic graph (DAG)-based regression modelling directs greatest focus towards modelling mean structures
(i.e. ‘fixed’ effects), whereas simulation approaches embrace complexity by focusing more on ‘random’ structures.
• Microsimulation modelling provides a bridge between DAG-informed regression modelling and agent-based model-
ling, which may be exploited to bring the mathematical robustness of graphical model theory to bear on simulation
approaches.
• Agent-based modelling can provide a complimentary extension to DAG-informed regression methods in order to
deal with scenarios involving greater complexity (e.g. in which the assumption of no ‘interference’ or spillover effects
may be untenable).
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modelling for statistically minded researchers who may be
relatively unfamiliar with them; moreover, we describe
DAG-informed regression modelling for simulation-
minded researchers. Because these methods have largely
been confined to separate research disciplines, there exists
little overlap in the knowledge about them and skills nec-
essary for implementing them, despite calls for greater in-
tegration2,13,15,17; our paper aims to fill this gap. We
begin by briefly explaining each method and its history,
and go on to discuss how their separate evolutions have
shaped the types of causal questions to which they are
well suited to evaluating. We outline the primary philo-
sophical and methodological similarities and differences
between them, and conclude with a discussion regarding
the implications of these similarities and differences for fu-
ture causal analyses and opportunities for future methodo-
logical work.
A brief history of methods
Historical context is key to understanding both the utility
and the defining features of a particular method; therefore,
we briefly recap the history of each method, with specific
attention given to how it evaluates counterfactuals (see
Box 1 for an explanation of counterfactuals).
Graphical causal models and the formalization of
counterfactuals
Causal models trace their roots back to 1918, with Sewall
Wright’s invention of path analysis.19,20 They also have
origins in structural equation models (SEMs), which
emerged primarily in the social sciences (e.g. psychology)
and represent groups of causally related variables (both ob-
served and latent) as systems of simultaneous (linear) equa-
tions.21 However, both were subsumed at the turn of the
century under the framework of non-parametric causal
models by Judea Pearl in his seminal book Causality.22
These models are typically represented graphically as a set
of nodes (variables) connected by a set of edges (represent-
ing statistical dependencies), although neither the magni-
tude nor functional form of these dependencies are implied
or constrained.23 A special subset of such graphs—
DAGs—are perhaps the most well known.
A DAG is a graphical causal model in which all edges
are unidirectional (hence ‘directed’); these directed edges
represent direct causal effects. A path is a sequence of
edges connecting two nodes, and there may be multiple
paths connecting any two nodes. A causal path is one in
which all directed edges flow in the same direction, indicat-
ing that the statistical dependency that exists between the
nodes is causal in nature. Importantly, no causal paths may
exist from any node back to itself (hence ‘acyclic’).23,24
A node may be either endogenous (having at least one di-
rect cause represented in the DAG) or exogenous (having
none), and a DAG may be considered a ‘causal DAG’ if all
common causes between any two nodes are represented in
the graph.24 A simplified example is given in Figure 1,
showing the hypothesized causal relationships between
sex, weight and systolic blood pressure (SBP).
DAGs represent a given system as a number of variables
connected by a series of causal pathways; combined with
parametric assumptions, they may be thought of as repre-
senting the presumed data-generating process, i.e. the pro-
cess by which any endogenous variable in the system
obtains its value. Given the values for all exogenous varia-
bles, the value of any endogenous variable can be known.
For example, if we knew the value of sex in Figure 1 (and
assumed it was a causal DAG for ease of illustration,
though in reality this is unlikely), we could also know the
values of weight and SBP, because weight depends only
Figure 1. Directed acyclic graph (DAG) depicting the hypothesized
causal relationships between sex, weight and systolic blood pressure
(SBP).
Box 1. A brief explanation of counterfactuals
Counterfactuals
The counterfactual framework states that an event A
may be considered a cause of an event Y if, contrary
to fact, had A not occurred then Y would not have oc-
curred.4 As an example, imagine that an individual,
Alison, is driving to work and comes to a fork in the
road. She chooses to go left, and arrives late for work.
Upset, Alison declares ‘I should have gone right in-
stead!’ What her statement implies is that her decision
to go left at the fork in the road caused her to be late
for work because had she gone right she would not
have arrived late. Of course, there is no way to prove
such a statement, as it would require Alison to simul-
taneously go both left and right and observe the out-
come under each condition (to guarantee that the ef-
fect is not attributable to any other factor that differed
between drives); nevertheless, the scenario demon-
strates the utility of examining causal effects as coun-
terfactual contrasts between two exchangeable units
of analysis—those that are equivalent in every way ex-
cept for the putative causal factor of interest.
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upon sex for its value, and SBP in turn depends upon
weight and sex.
Whilst identification of individual-level causal effects is
generally agreed to be impossible in the real world within a
counterfactual framework (i.e. ‘the fundamental problem
of causal inference’), identification of average causal effects
is possible and, indeed, forms the basis of a great deal of
causal inference.24 Randomized–controlled trials (RCTs)—
often considered the ‘gold standard’ for demonstrating
causality—create exchangeable units of analysis by ran-
domly assigning individuals to receive either the putative
causal factor of interest or a standard alternative that acts
as the reference (e.g. placebo control). Thus, although indi-
viduals within the study likely differ with respect to both
measured and unmeasured characteristics that may affect
the outcome of interest, randomization ensures that the
distribution of such factors is broadly equivalent between
the groups so that, on average, the two groups are ex-
changeable and thus any difference in average outcomes
may be attributed to the hypothesized causal factor.24
DAGs are an incredibly powerful tool for statistical
analyses because they provide the foundation for estimat-
ing counterfactual quantities from observed data; they
have thus found a natural home amongst disciplines in
which data collection and statistical analysis are consid-
ered paramount (e.g. epidemiology). Creating exchange-
able units of analysis is trivial in a well-conducted RCT but
more difficult to achieve with non-experimental data in
which the putative causal factor of interest is not randomly
assigned; simply comparing the average outcomes between
those who were or were not exposed to that factor would,
in general, not be sufficient for identifying an average
causal effect, since the differences in outcomes might be at-
tributable to other differences between the groups.
However, in principle, identification of a causal effect
could be achieved by comparing the outcomes amongst
subgroups for which the distributions of relevant factors
are broadly equivalent. Such subgroups would therefore be
referred to as conditionally exchangeable (or exchangeable
conditional on these factors).
The power of graphical model theory is that it provides
a way of determining which variables are sufficient for
guaranteeing conditional exchangeability for a given DAG,
thereby formalizing counterfactual logic and facilitating
what has been referred to as the ‘algorithmisation of coun-
terfactuals’.25 Briefly, a set of variables is sufficient for
guaranteeing conditional exchangeability if conditioning
on that set blocks all ‘backdoor paths’ (i.e. spurious paths
that induce statistical dependence due to one or more com-
mon causes—referred to as ‘confounding’) between the pu-
tative causal factor and outcome of interest whilst leaving
all causal paths intact.23 In practice, this generally involves
creating a regression model for the outcome that includes
as covariates both the putative causal factor and a set of
variables sufficient for removing bias due to confound-
ing.23 In Figure 1, for instance, sex confounds the relation-
ship between weight and SBP; therefore, if we wished to
estimate the total causal effect of weight on SBP, we could
estimate the parameters of the following regression model:
SBP ¼ b0 þ b1 weight þ b2  sexþ e:
Assuming that the model has been correctly parameter-
ized, we are able to interpret b^1 as the estimated total
causal effect of weight on SBP. In other words, for individ-
uals of the same sex (i.e. conditionally exchangeable indi-
viduals), every unit-difference in weight corresponds to an
expected difference in SBP of b^1, on average. DAGs there-
fore provide a framework for using traditional statistical
methods to estimate counterfactual quantities and average
causal effects via the creation of conditionally exchange-
able units of analysis.
Microsimulation models, agent-based models and
the simulation of counterfactuals
Microsimulation and agent-based modelling are closely
linked methodologically and conceptually though histori-
cally distinct, which perhaps obfuscates where they in fact
overlap and where they diverge. Both have roots in cellular
automata,26 which first emerged in the 1940s and involve
simulating the evolution of a collection of coloured cells
within a grid at discrete time steps in accordance with a set
of rules based on the states of neighbouring cells. From
this, MSMs and ABMs evolved separately (primarily in
economics and sociology, respectively) as more complex
simulation methods; their development and implementa-
tion were greatly enabled by the advent of programmable
electronic computers. Whereas both methods have been in
use for approximately the last half-century—with Orcutt27
frequently credited as one of the founding fathers of the
field of microsimulation and Schelling28 for agent-based
modelling—the vast increases in computing power realized
in the age of technology have rendered early implementa-
tions virtually unrecognizable in comparison to their mod-
ern counterparts.29–33
In its most basic form, microsimulation is a method
for generating micro-level data, typically by combining in-
dividual- and aggregate-level datasets (i.e. population syn-
thesis)34; this provides an estimated cross-sectional
snapshot of a population. This synthetic population may
then be statistically analysed to examine associations
between its variables (as in ‘traditional’ data analysis) or,
perhaps more interestingly, it can provide the foundation
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for a dynamic simulation model (either MSM or ABM).
Both dynamic MSMs and ABMs simulate the evolution of
heterogeneous individuals through time and potentially
space. Each individual possesses a set of attributes (e.g.
physical, socio-demographic, geographic), which may be
updated at discrete time steps; in microsimulation models,
in particular, individuals are often defined as belonging to
one of a finite number of mutually exclusive and collec-
tively exhaustive states (e.g. healthy, sick and dead), and
events of interest are modelled as transitions from one state
to another that occur according to a set of deterministic
and/or stochastic rules (‘transition probabilities’) defined
by the modeller.35–37 Conceptualized in this way, one may
see parallels between the data-generating process repre-
sented by a DAG and the process by which individuals
(and their attributes) evolve within the simulations.
Where MSMs and ABMs usually diverge, however, is in
the level of complexity in the assumptions each adopts
and adheres to regarding the underlying data-generating
processes. A defining feature of ABMs—and what often
separates them from MSMs—is the presence of interac-
tions amongst individuals34; however, the distinction is pri-
marily philosophical rather than methodological.
Individuals within an ABM are explicitly conceptualized as
agents—i.e. as autonomous, adaptive individuals with
bounded rationality.3 Often this agency manifests in the
form of responding to and making decisions influenced
by other individuals within the simulation; such agent-to-
agent interaction may give rise to what is referred to in the
epidemiological literature as ‘interference’, and makes
both representation of the scenario as a DAG and subse-
quent statistical estimation of causal effects considerably
more complex38–40 because the focus is no longer limited
to central locations (i.e. means) but rather the entire distri-
bution of values for each variable as dictated by
individual-level interactions. Within a standard DAG (e.g.
Figure 1), each variable has a distribution of values across
individuals that is determined by the variables that causally
precede it; within an ABM, that distribution has an addi-
tional within-variable dependency on individual-level rela-
tionships. Thus, the data-generating process of an MSM is
more easily represented by a DAG (as in Murray et al.18)
than that of an ABM.
The potential of both MSMs and ABMs to evaluate
counterfactual scenarios (or ‘what if’ scenarios17) should
be immediately apparent. The modeller may alter e.g. one
or more transition probabilities (or features of the agent-
to-agent interaction, if applicable), cluster effects or some-
how fix or limit the values allowable for any attribute, and
then allow the effects of such perturbations to play out in
the simulation. MSMs and ABMs inherently provide ex-
changeable units of analysis, as each simulated run serves
as a counterfactual scenario given that the initial popula-
tion remains unchanged.16
How historical differences have informed
philosophical and methodological
differences
Examining the history of each method, as we have done in
the previous section, is useful because historical knowledge
is integral to understanding why each evolved in the partic-
ular discipline(s) it did and thus what types of causal ques-
tions it is well suited to addressing. After all, methods are
simply tools developed to accomplish some particular
objective; it is no coincidence that the three methods
considered here have largely evolved in their separate disci-
plines. Hernan41 has provided a particularly interesting
commentary on DAG-based regression modelling and sim-
ulation modelling, framing their differences in terms of
their relative reliance on data vs theory—with DAG-
informed models being more reliant on data and ABMs
more on theory—and thus reflecting the relative value
placed on data and theory within the disciplines in which
they are typically used. We illuminate additional differen-
ces between the three methods that arise from their sepa-
rate historical evolutions, including their relative focus on
fixed vs random effects, and the timescales and timeframes
in which they operate.
Research questions
Due to its historical methodological foundations in the
field of medicine, epidemiology (though arguably a social
science) has tended to direct greater focus towards causal
questions that lend themselves to experimentation, in an
attempt to make inferences as independent as possible of
theoretical arguments.41 Even when experimentation is in-
feasible, large quantities of (observational) individual-level
data are collected and statistical methods (e.g. regression
modelling) are employed with the aim of mathematically
controlling for those factors that would typically be con-
trolled via experimental manipulation. The recent revolu-
tion in graphical model theory has provided a theoretical
foundation for causal data analysis that has historically
been lacking, but it nevertheless remains that epidemiology
is a data-loving science. Consequently, as noted by
Hernan,41 minimizing (albeit not eliminating) the role of
theory has necessitated addressing narrower causal ques-
tions. This is the context in which DAGs have been
employed and in which the majority of methodological
work is ongoing.42,43 Disciplines such as sociology and
psychology, however, tend to be interested in answering
broader, more theory-driven questions relating to
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phenomena for which data do not exist or may be difficult
to measure or quantify (e.g. social norms); the theory-
driven, data-generative nature of ABMs makes them more
suitable for modelling such contexts. Economics—the pri-
mary realm of MSMs—falls somewhere in between, and in-
deed the discipline has shown a greater willingness to
embrace graphical model-based methods (e.g. instrumental
variable analysis44) than some of the ‘softer’ social sciences.
As an illustration of how use of the three methods dif-
fers, we consider obesity as a case study. The obesity epi-
demic has previously been characterized as containing
many features of a complex system2,3,45 as well as elements
from a wide variety of disciplines (e.g. biology, social pol-
icy, economics, psychology, geography, etc.); thus, it offers
an ideal context for comparing the methods of interest.
Box 2 provides a sample of the stated research objectives
for published studies that have examined obesity using
DAG-informed regression modelling, microsimulation
modelling or agent-based modelling. Examination of Box
2 reveals several interesting distinctions between the meth-
ods; it also illustrates the observation by Hernan41 that
DAG-informed regression modelling and agent-based
modelling exist along a spectrum according to the relative
weights given to data and theory, with microsimulation
modelling providing a bridge between them.
The research questions addressed by DAG-informed re-
gression modelling in Box 2 tend to be framed in terms of
estimating the effect of a specific factor on a specific out-
come. The concept of intervention is often implicit in these
analyses (e.g. ‘If we were to intervene to alter exposure to
early-life persistent organic pollutions, how would this af-
fect BMI?’, as in Karlsen et al.59), but may also be explicit,
as in Danaei et al.56 In fact, the example of Danaei et al.56
is particularly enlightening due to its specific use of the g-
formula, which—as has previously been noted by Murray
et al.18—is broadly equivalent to microsimulation, because
it effectively simulates the joint distribution of the variables
in a DAG that would have been observed had an interven-
tion been enacted in which all individuals were exposed to
the putative causal factor of interest.46
Researchers using microsimulation modelling tend to
exclusively focus on estimating the effect of a specific pol-
icy or intervention on a target outcome and, often, deter-
mining its cost-effectiveness.37,67 Inherent in and integral
to these analyses are specific comparisons between alterna-
tive intervention programmes. Given its history in the field
of economics, it is perhaps unsurprising but nevertheless il-
lustrative that microsimulation modelling is used for such
analyses, particularly when contrasted with analyses using
agent-based modelling.
The explicit evaluation of interventions in microsimula-
tion modelling crosses over to agent-based modelling, with
several of the stated research objectives in the third column
of Box 2 referring to specific hypothetical policy interven-
tions. However, unique to agent-based modelling analyses
is their exploration of social phenomena (e.g. economic
segregation, social norms) in the simulation framework.
Thus, although they share considerable overlap methodo-
logically, microsimulation and agent-based modelling are
distinct in their underlying purposes and practical utility.
Moreover, because agent-to-agent interactions give rise to
greater complexity, ABMs often result in highly nonlinear
and chaotic states and produce ‘emergent’ properties68;
consequently, ABMs are less suited than MSMs to produc-
ing the detailed predictions often required by economists
and policymakers, but arguably more suited to modelling
naturally complex social phenomena.
Fixed vs random effects
Another—perhaps underappreciated—distinction between
DAG-informed regression models and ABMs is their
relative focus on fixed vs random effects, which also arises
from their distinct historical evolutions. A natural
consequence of using DAG-informed regression models is
that intense focus is directed towards modelling mean
structures and estimating mean (fixed) effects as opposed
to evaluating distributional properties and understanding
complexity by examining variation and the patterns of nat-
ural heterogeneity. Although DAGs describe causal pro-
cesses that could potentially manifest in infinitely many
(parametric) ways, the use of regression models to interro-
gate causal questions and identify average causal effects
makes focus on the distributional properties of the varia-
bles of interest effectively redundant. Moreover, their
mathematical foundation is built on the assumption of no
interference or spillover effects, and so the complexity and
heterogeneity that define a complex system are often
strictly controlled via study design or averaged out and
largely overlooked (thereby treated more as a nuisance and
mere ‘noise’ than of substantive interest in its own right).
However, it is undeniable that there are myriad determi-
nants of health and disease—particularly social ones15—
that operate on many levels and in a complex fashion, and
about which the ‘random’ structures (possibly arising from
individual interactions) are of equal, if not greater, impor-
tance to the ‘fixed’ structures. Such determinants may be
of great interest to epidemiologists, yet statistical model-
ling is limited in the insights it can provide into the poten-
tial complexity of random structures that contain spillover
effects and interference. For these reasons, causal questions
involving such complexities have tended to be relegated to
the social sciences, in which greater emphasis is placed on
theory as opposed to data (i.e. the realm of ABMs).
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Box 2. A sample of the stated research objectives for published studies that have examined obesity using DAG-
informed regression modelling (* denotes use of a ‘g-method’46), microsimulation modelling or agent-based modelling
DAG-informed regression modelling Microsimulation modelling Agent-based modelling
‘. . . to estimate the joint effects of
obesity and smoking on all-cause
mortality and investigate whether
there were additive or multiplica-
tive interactions.’47*
‘. . . to establish whether 52-week refer-
ral to an open-group weight-manage-
ment programme would achieve
greater weight loss and improve-
ments in a range of health outcomes
and be more cost-effective than the
current practice of 12-week
referrals.’48
‘To explore the role that economic seg-
regation can have in creating income
differences in healthy eating and to
explore policy levers that may be ap-
propriate for countering income dis-
parities in diet.’49
‘. . . to estimate the independent
causal effects of body mass index
[. . .] and physical activity on cur-
rent asthma.’50*
‘. . .to estimate the expected impact of
the [1-peso-per-litre] tax [on sugar-
sweetened beverages] on body
weight and on the prevalence of over-
weight, obesity and diabetes in
Mexico.’51
‘. . . [to compare] the effects of targeting
antiobesity interventions at the most
connected individuals in a network
with those targeting individuals at
random.’52
‘. . . to study whether weight-related
anthropometrics, changes in BMI
SDS [standard deviation score]
and physical activity at different
ages in childhood are associated
with atopic disease by late
childhood.’53
‘. . . to estimate changes in calorie intake
and physical activity necessary to
achieve the Healthy People 2020 ob-
jective of reducing adult obesity prev-
alence from 33.9% to 30.5%.’54
‘. . . [to] simulate how a mass media
and nutrition education campaign
strengthening positive social norms
about food consumption may poten-
tially increase the proportion of the
population who consume two or
more servings of fruits and vegeta-
bles per day in NYC.’55
‘. . . to estimate the 26-year risk of
CHD [coronary heart disease] un-
der several hypothetical weight
loss strategies.’56*
‘To assess the cost-utility of gastric by-
pass versus usual care for patients
with severe obesity in Spain.’57
‘. . . [to explore] the efficacy of a policy
that improved the quality of neigh-
borhood schools in reducing racial
disparities in obesity-related behav-
iour and the dependence of this effect
on social network influence and
norms.’58
‘. . . [to evaluate] the associations be-
tween early-life POP [persistent or-
ganic pollutant] exposures and
body mass index.’59
‘To analyse the cost-effectiveness of
bariatric surgery in severely obese
(BMI ? 35 kg/m2) adults who have
diabetes.’60
‘. . . to examine: a) the effects of social
norms on school children’s BMI
growth and fruit and vegetable (FV)
consumption, and b) the effects of
misperceptions of social norms on
US children’s BMI growth.’61
‘. . . to assess the mediating role of
anthropometric parameters in the
relation of education and inflam-
mation in the elderly.’62
‘To estimate the impact of three federal
policies on childhood obesity preva-
lence in 2032, after 20 years of
implementation.’63
‘. . . to examine the effects of different
policies on unhealthy eating
behaviors.’64
‘. . . to examine differences in the
contribution of obesity measures
to adenoma risk by race.’65
‘To determine the cost-effectiveness of
gastric band surgery in overweight
but not obese people who receive
standard diabetes care.’66
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Foundationally, ABMs are theoretically very different
from their statistical counterparts; as recognized by
Oakes,69 the outcome of interest is primarily the process
by which group phenomena emerge. From the (micro-)sim-
ulated processes of ABMs, patterns and properties of the
system emerge; mean effects may be eventually derived,
but the primary focus is on conceptualizing and modelling
the system as a whole, and how individual agency and het-
erogeneity interact to give rise to aggregate patterns.
Although ABMs have seen some use within epidemiology,
this is largely confined to the study of infectious diseases70–73
in which there exist clear transmission mechanisms via in-
dividual interaction74 and in which it is widely recognized
that the effects of interaction are a fundamental part of the
causal mechanism and thus cannot be overlooked.38
Although the random effects arising from agent-to-agent
interactions in ABMs are absent in MSMs, individuals re-
main the central focus of MSMs rather than average pat-
terns. This individual-level focus allows the analysis of
heterogeneity and distributional properties that might be
masked by approaches considering only mean effects.33,37
Timescale and timeframe
There also exists a large divergence between DAG-informed
regression modelling and microsimulation/agent-based
modelling with regard to how time is incorporated into the
analyses—in terms of both scale and frame. Time is an in-
herent factor in any causal analysis, though there are infi-
nitely many possibilities regarding the scale at which it is
conceptualized and modelled. Because all models are
abstractions of reality, both the salient features of a system
and the frequency at which they are measured and repre-
sented are subjective choices that depend on context (and
convenience, in the case of data-dependent analyses). For
example, individual activity levels might be modelled every
few seconds (as recorded by an activity monitor) to discover
how exercise relates to heart rate during high-intensity inter-
val training. However, such granularity would likely be un-
necessary for determining how exercise relates to adipose
tissue levels, in which case individual activity levels might be
recorded as an average daily, weekly or monthly value; on
the other hand, insufficient granularity of timescale (e.g.
yearly or bi-yearly averages, or a one-time cross-sectional
measurement) could have a detrimental impact on any anal-
yses, as the circular feedback loop that occurs—typically on
a much smaller timescale—between physical activity and
obesity would be masked.
In general, the timescales upon which both methods
operate are strikingly different. MSMs and ABMs tend to
model much smaller timescales (e.g. days, weeks, months)
than do statistical models because these are closer to the
timescales upon which human behaviour and interactions
generally operate, and upon which the effects of policy inter-
ventions might be realized. For ABMs in particular, in which
agent-to-agent interactions are integral to the causal processes
operating (e.g. for infectious diseases), modelling geolocation
with high frequency is essential. Greater granularity of time-
scale enables the accumulation of emergent properties—
although modelled in discrete time steps—to be approxi-
mately smoothed. Moreover, abstraction to larger scales has
the potential to miss out on the complexity that these models
seek to explore and/or explain and, because they are not as
limited by data availability, they are able to explore phenom-
ena in such granularity when the context requires it. Although
DAG-based regression models are theoretically able to model
such small timescales, their reliance on data (which tend to be
collected infrequently, as in observational health studies, for
instance) limits this in practice; they tend to be parameterized
in a less granular fashion, which additionally serves their fo-
cus on mean effects and model parsimony.
Additionally, the timeframes in which the different mod-
els operate diverge. Because they are reliant upon data,
DAG-based regression models exclusively model past events;
the counterfactuals created are thus thought experiments
about what would have happened had some condition been
different. However, public health and epidemiological
researchers are generally interested in estimating causal
effects because they wish to intervene to alter (ideally benefi-
cially) future health states; they may extrapolate the results
of their statistical models to infer that what would have hap-
pened in the past is equivalent to what would happen in the
future, but they do not explicitly model this. In contrast,
MSMs and ABMs may be used to model both past and fu-
ture events by utilizing and synthesizing historical data and
estimates to make decisions about hypothetical future inter-
ventions; indeed, estimating the future impact of potential
policy interventions has historically been fundamental to the
utility of these methods.33,37,75
Discussion
The identifying features of each of DAG-informed
regression modelling, microsimulation modelling and
agent-based modelling are briefly summarized in Table 1;
we also include concise summaries of their accepted
strengths and weakness.
As have previously been detailed, there exist substan-
tive historical, theoretical and methodological differen-
ces between DAG-informed regression modelling,
microsimulation modelling and agent-based modelling
that make them suited to addressing different types of
causal questions. DAG-informed regression modelling is ap-
propriate for analyses in which the query of interest can be
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explicated in the traditional language of ‘exposures’ and
‘outcomes’ (e.g. ‘What is the effect of gastric bypass surgery
[the exposure] on risk of diabetes [the outcome]?’), for
which sufficient individual-level data are available on a suit-
able timescale for the causal processes of interest, and for
which spillover effects and interference are thought to be
negligible. Moreover, in terms of their practical utility in
policy-making decisions, they are better suited to evaluating
exposures/interventions whose effects can be safely assumed
to be more or less transportable across time, so that the
effects estimated from past data may be carried forward to
the hypothetical future. When such conditions are met,
DAG-informed approaches provide a robust method for
causal inference whilst requiring relatively few assumptions,
and offer a transparent means for communicating those
assumptions.
At the other end of the spectrum, ABMs provide a means
for modelling greater complexity—e.g. in the form of indi-
vidual interactions and spillover effects—though they do so
by requiring a greater number of assumptions. Moreover,
because they model scenarios in which key variables of inter-
est may not lend themselves to numerical representation, or
in which observed data are not sufficiently granular in time-
scale to fully inform parameterization and/or enable
effective validation, ABMs inherently contain greater
uncertainty about the validity of their causal effect esti-
mates.77,79,80 Here, MSMs offer a useful halfway house:
they may be able to utilize the robust foundations of graphi-
cal causal models and also explore the effects of potentially
complex interventions that occur over prolonged periods of
time, possibly in the future. The results of Murray et al.18,81
(which demonstrate equivalence between the g-formula and
microsimulation, and use the g-formula to inform microsi-
mulation model parameters) represent the first endeavours
to bring the mathematical robustness of graphical model
theory to bear on simulation approaches. Further methodo-
logical research in this area promises to be fruitful.
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Table 1. Brief summaries of the key features, strengths and weakness of each of DAG-informed regression modelling, microsi-
mulation modelling and agent-based modelling. Note that the lists of strengths and weaknesses is not intended to be
exhaustive
DAG-informed regression modelling Microsimulation modelling Agent-based modelling
Short description/
key features
Variables connected by causal pathways
representing the data-generating
process; used to inform statistical
(regression) models
Simulated individuals that evolve over
time, often transitioning between
‘states’
Simulated individuals that evolve
over time and interact with one
another, producing ‘emergent’
properties
Other common
names/examples
• G-methods76 (parametric g-formula,
inverse probability of treatment
weighting of marginal structural
models, g-estimation of structural
nested models)
• Individual-based (simulation) models
• First-order Monte Carlo models77
• State transition models37
• Individual-based (simulation)
models
• Dynamic (transmission) models78
Strengths • Backed by formal mathematics of
graphical model theory
• Provide robust estimates of causal
effects for clearly defined exposures
and outcomes
• Assumptions underlying each model
are transparent
• Can evaluate the (future) effects of al-
ternate intervention strategies
• Can combine parameter estimates from
multiple datasets
• Greater focus on outcome distributions
• Capable of modelling feedback
loops and spillover effects
• Can incorporate hard-to-mea-
sure concepts and individual
agency
• Capable of modelling future
timeframes
• Greater focus on outcome
distributions
Weaknesses • Require large individual-level datasets
• Not naturally suited to modelling longi-
tudinal scenarios
• Primarily focus on mean (average)
effects
• Combination of parameter estimates
from different populations may result
in bias18
• Small parameterization errors may be
perpetuated throughout the simulation
and result in large biases
• Model complexity makes pa-
rameterization, calibration and
validation difficult
• Lack of consensus about funda-
mental assumptions or under
what circumstances causal effect
estimates are valid16
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